Hubei Goto Biopharm Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 267.56 million compared to CNY 268.24 million a year ago. Revenue was CNY 267.82 million compared to CNY 268.35 million a year ago.

Net income was CNY 17.47 million compared to CNY 26.98 million a year ago. Basic earnings per share from continuing operations was CNY 0.15 compared to CNY 0.2341 a year ago. Diluted earnings per share from continuing operations was CNY 0.15 compared to CNY 0.2217 a year ago.